Ibandronate [ibandronic acid] with or without capecitabine in elderly patients with early breast cancer
Latest Information Update: 10 Oct 2023
At a glance
- Drugs Capecitabine (Primary) ; Ibandronic acid; Ibandronic acid
- Indications Carcinoma; Early breast cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms ICE
- 07 Sep 2023 Results(n=1409) published in the European Journal of Cancer.
- 14 Dec 2019 Results (N= 15,457), a metanalysis of prospective randomized trials assessing efficacy of Capecitabine as a part of neo adjuvant or adjuvant therapy in patients with early breast cancer, presented at the 42nd Annual San Antonio Breast Cancer Symposium
- 13 Dec 2014 Results presented at the 37th Annual San Antonio Breast Cancer Symposium.